Jay Keasling, Associate Laboratory Director for Biosciences, has announced that Paul Adams has accepted the position of Division Director for the Molecular Biophysics & Integrated Bioimaging (MBIB) Division. Adams served as the MBIB Interim Division Director since the Biosciences Area re-organization took effect this past October 1 and has been instrumental in developing a strategic plan and leading the effort to launch the Division.
Improving Anti-Influenza Medications
The annual flu epidemics caused by influenza viruses, especially the influenza A virus, affect about 10–20% of the world’s population each season. This highly contagious illness can trigger serious complications and lead at times to death. A team of scientists led by Bill DeGrado from UC San Francisco have been studying the M2 proton channel from the influenza A virus, which is one of nature’s smallest proton-selective channels and a drug target for this virus. Protein crystallography performed at the Advanced Light Source (ALS) Beamline 8.3.1 helped scientists understand the M2 proton-channel structure and function, and will aid the design of better anti-influenza medications. Read the ALS Science Brief.
Biosciences Area FY16 LDRD Projects
The projects of eleven Biosciences Area scientists and engineers received funding through the FY2016 Laboratory Directed Research and Development (LDRD) program. These projects cover a broad range of topics, including energy science technology applications, novel computing technologies, and mechanistic understanding of multi-scale interactions among molecules, microbes, plants, metazoans, the abiotic environment, and their feedbacks. Together, these efforts account for nearly 14% of the $25.3 million allocated. Lab-wide, 84 proposals were selected from a field of 179.
DOE-funded Bioenergy Research Centers File 500th Invention Disclosure
Three U.S. Department of Energy-funded research centers – the BioEnergy Science Center (Oak Ridge National Laboratory), the Great Lakes Bioenergy Research Center (University of Wisconsin–Madison and Michigan State University), and the Joint BioEnergy Institute (Lawrence Berkeley National Laboratory) – are making progress on a shared mission to develop technologies that will bring advanced biofuels to the marketplace, reporting today the disclosure of their 500th invention. Read more on the JBEI website.
Tracking the Onset of Azheimer’s
New research shows for the first time that PET scans can track the progressive stages of Alzheimer’s disease in cognitively normal adults, a key advance in the early diagnosis and staging of the neurodegenerative disorder. William Jagust, senior faculty scientist in the Molecular Biophysics & Integrated Bioimaging Division, is the study’s principal investigator. A video abstract of the findings, published March 2 in the journal Neuron, can be found here. Read more at UC Berkeley News.
- « Previous Page
- 1
- …
- 183
- 184
- 185
- 186
- 187
- …
- 203
- Next Page »
Was this page useful?